WAY 316606 Powder CAS.915759-45-4 99% Min
video
WAY 316606 Powder CAS.915759-45-4 99% Min

WAY 316606 Powder CAS.915759-45-4 99% Min

Product name: WAY 316606 Powder
CAS No.915759-45-4
Molecular formula: C₂₁H₂₄O₂
Molecular weight: 308.42
Purity: 99.0%
Capacity: 100kgs per month
Source: synthetic
Purity (HPLC) >98.0%
Place of Origin: China Yinherb-Lab
Packing: As per client's requirements
Minimum Order Quantity: 1kg
Storage: Store in cool & dry place, Keep away from strong light and heat for 2 years

Description

Xi’an Yinherb Bio-Tech Co., Ltd. is one of the leading manufacturers and suppliers of way 316606 powder cas.915759-45-4 99% min in China, also supports customized service. Welcome to buy bulk way 316606 powder cas.915759-45-4 99% min for sale here from our factory. Quality products and reasonable price are available.

 

 

202510311206291237410
Leading Research lab on Nootropics & peptide in China

Yinherb Lab is a professional research Lab in china, have focused on Nutritional Supplements, Nootropics and Peptide raw materials researching and producing in this market for over 10 years with stable quality and great reputations, we can supply every batch test, including COA, HPLC and NMR. I believe that we must work well in future.

Yinherb Lab High Quality WAY 316606 Powder CAS.915759-45-4 99% Min

Product name: WAY 316606

Chemical Name: 4-[(E)-2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)ethenyl]benzoic acid

CAS Number: 446292-06-6

Molecular Formula: C₂₁H₂₄O₂

Molecular Weight: ~308.42

Drug Class: Selective retinoic acid receptor gamma (RARγ) agonist

Purity Standard: ≥98% (pharmaceutical R&D grade; verified by HPLC/NMR)

Purity: ≥98.0% (HPLC assay)

Single Impurity: ≤1.0% (individual impurity)

Total Impurities: ≤2.0%

Loss on Drying: ≤0.5% (105°C, 2 hours)

Residue on Ignition: ≤0.1%

Solvent Residues: Complies with ICH Q3C (for R&D use)

Appearance: White to off-white crystalline powder, odorless

Solubility: Insoluble in water; soluble in organic solvents (DMSO: ≥100 mg/mL, ethanol: 20–30 mg/mL, acetone: 15–25 mg/mL)

Melting Point: Approximately 228–232°C (DSC analysis)

Stability: Stable under cool, dry, dark conditions; sensitive to UV light, strong acids, and oxidizing agents

 

What is WAY 316606 Powder?

WAY 316606 Powder (CAS 915759-45-4, ≥98% HPLC) is a potent, selective sFRP‑1 inhibitor that activates Wnt/β‑catenin signaling. It is widely used in anti‑hair loss research, osteoporosis studies, and high‑end scalp care cosmetics. With dual efficacy in stimulating hair follicle growth and promoting bone formation, it serves as a critical tool compound for Wnt pathway research and a promising lead for hair growth and anti‑osteoporosis drug development. High purity, stable quality, and good solubility make it ideal for research, cosmetic formulation, and pharmaceutical R&D.

Core Features

High‑purity, selective sFRP‑1 inhibitor with potent Wnt signaling activation.

Demonstrates dual efficacy in stimulating hair follicle growth and promoting bone formation.

High selectivity for sFRP‑1 (≥10× over sFRP‑2) minimizes off‑target effects.

Good solubility in organic solvents enables easy formulation for research, cosmetics, and preclinical studies.

Strict quality control ensures batch‑to‑batch consistency and reliable experimental reproducibility.

RU58841-1-1

 

12


WAY 316606 Powder Mechanism of Action

WAY-316606's hair-regrowth effect is rooted in selective RARγ activation-a non-hormonal pathway critical for hair follicle cycling and regeneration:

RARγ Targeting: Binds specifically to retinoic acid receptor gamma (RARγ), expressed abundantly in hair follicle stem cells and dermal papilla cells.

 

Initiates Anagen Phase: Activates downstream genes (e.g., Shh, Wnt) that trigger the transition from telogen (resting) to anagen (growth) phase, reducing hair shedding.

 

Enhances Follicle Regeneration: Stimulates proliferation of hair follicle stem cells and dermal papilla cells, reversing miniaturization of androgenetic alopecia-affected follicles.

 

Synergistic with Minoxidil: Preclinical data shows it amplifies minoxidil's efficacy by improving follicle responsiveness to growth signals (no direct DHT blocking).

 

WAY 316606

 

WAY 316606 Powder Applications & Formulation Guidelines

Primary Use

Hair Loss R&D: Core raw material for preclinical/clinical studies on androgenetic alopecia (male/female) and alopecia areata.

Potential Formulations: Topical serums, lotions, or microneedle patches (systemic absorption is minimal for RARγ agonists).

 

Formulation Compatibility

Optimal Concentration: 0.01–0.1% (R&D formulations; higher concentrations may cause scalp irritation).

Compatible Excipients: Ethanol, propylene glycol, DMSO (small amounts as penetration enhancers), HPMC (thickener), panthenol (soothing agent).

Incompatible Substances: Strong acids/bases, UV-sensitive ingredients, high-moisture formulations (without preservatives).

Comparison Table: Similar Hair Loss Treatment Ingredients

Comparison Dimension WAY-316606 Powder Minoxidil Finasteride Clascoterone/Fluridil SM04554
Target Pathway Selective RARγ activation (retinoic acid receptor gamma) Potassium channel opening + angiogenesis 5α-reductase inhibition (reduces DHT production) Androgen receptor antagonism (blocks DHT-follicle binding) Wnt pathway activation (GSK-3β inhibition)
Mechanism Focus Follicle stem cell proliferation + anagen phase initiation Extends anagen phase + improves follicle blood supply Halts DHT-mediated follicle miniaturization (hormonal blocking) Halts DHT-mediated follicle miniaturization (local receptor blocking) Reverses follicle miniaturization + stem cell differentiation
Hormonal Interaction None (non-hormonal; no DHT/testosterone impact) None (non-hormonal) Strong hormonal modification (reduces systemic DHT) None (local anti-androgen; no systemic hormone change) None (non-hormonal)
Key Advantage Synergistic with minoxidil (amplifies efficacy); targets stem cell regeneration Gender-neutral; proven regrowth; widely available High potency for male pattern baldness Safe for men/women; no systemic side effects Stimulates new follicle formation (beyond just preserving existing ones)
Limitations Early R&D stage (no FDA approval); mild irritation at high concentrations Requires daily application; no effect on severe baldness Male-only use; sexual side effects; teratogenic risk for women Mild regrowth efficacy; slower onset than minoxidil Development suspended; limited commercial availability
Formulation Focus Topical (serums, microneedle patches); low concentration (0.01–0.1%) Topical (solutions/foams); 2–5% concentrations Oral (tablets); topical in development Topical (serums/lotions); 1–2% concentrations Topical (serums); 0.5–1% concentrations
Related products

Specized in Fevipiprant, Minoxidil, Fluridil, SM04554, Clascoterone CB-03-01, β-estradiol, WAY316606, etc.

  • Sunifiram-1
    Yinherb
    Sunifiram
  • -1
    Yinherb
    Nefiracetam
  • product-255-241
    Yinherb
    Fasoracetam
  • Noopept
    Yinherb
    Noopept
Shipping.jpg 3.png
Certifications

 

product-592-835

FDA

product-650-920

Halal

product-650-927

ISO 9001

product-650-920

Kosher

product-3969-5613

Audit Report

product-3969-5613

SGS

 

 

Yinherb Lab founded in 2009, has been deeply committed to the biotechnology field for over a decade. Today, it has established a professional development framework integrating "R&D + production" as an integrated system.  And always adhered to the core business philosophy of "Quality First, Service Second, Price Third".

Our address

No.3, Daqing rd, Hi-tech zone, Xi'an city, China.

Phone Number

+8618681897250

_20251031154528_1250_410.jpg

Hot Tags: way 316606 powder cas.915759-45-4 99% min, China way 316606 powder cas.915759-45-4 99% min manufacturers, suppliers, factory, Beta Estradiol Powder 99 Min, CAS 1360540 81 3, Fluridil Powder, RU58841 Powder, RU58841 Powder 99 Min, WAY 316606 Powder

You Might Also Like

Shopping Bags